The Center for Pediatric Genomic Medicine and the Experimental Therapeutics in Cancer program are conducting breakthrough research to better understand the genetic causes of pediatric cancer.
Pediatric Genomic Medicine
The Center for Pediatric Genomic Medicine at Children's Mercy Hospital is at the forefront of research to better understand the genetic causes of cancer, as well as the translation of that research to the bedside. Our oncology team is working with the genome center to sequence cancer genomes as they investigate the causes of childhood leukemia.
Our clinical pharmacology program and the Phase 1 Experimental Therapeutics in Cancer program, researchers are investigating how genetics may affect a patient’s reaction to individual drugs and treatments to help develop appropriate therapies and influence the formulation of new drugs.
Researching Leukemia in Hispanics
A research project focusing on the frequency of leukemia among Hispanics is also in development. The incidence of acute lymphoblastic leukemia is approximately 15 percent higher in Hispanics than in Caucasians, and through a partnership with a children’s hospital in Mexico, Children’s Mercy oncologists are expanding their investigation into the role genetic differences may play. Their work includes decoding the genome of leukemia cells.